Skip to main content

Muscle Invasive Bladder Cancer and the Staging Conundrum: Which Imaging Modality Is Best?

  • Chapter
  • First Online:
Management of Muscle Invasive Bladder Cancer

Part of the book series: Management of Urology ((MU))

  • 438 Accesses

Abstract

Urinary bladder cancer is a heterogeneous disease with a variety of pathologic features, cytogenetic (Verma et al., Radiographics 32:371–387, 2012). Early detection is important, since up to 47% of bladder cancer-related deaths may have been avoided (Verma et al., Radiographics 32:371–387, 2012). This chapter covers the staging conundrum.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Verma S, Rajesh A, Prasad SR, Gaitonde K, Lall CG, Mouraviev V, Aeron G, Bracken RB, Sandrasegaran K. Urinary bladder cancer: role of MR imaging. Radiographics. 2012;32(2):371–87.

    Article  Google Scholar 

  2. Yamada Y, Kobayashi S, Isoshima S, Arima K, Sakuma H, Sugimura Y. The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis. J Cancer Res Ther. 2014;10(4):878–82.

    Article  Google Scholar 

  3. Ohgiya Y, Suyama J, Sai S, Kawahara M, Takeyama N, Ohike N, Sasamori H, Munechika J, Saiki M, Onoda Y, Hirose M, Gokan T. Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T. Magn Reson Med Sci. 2014;13(3):175–81.

    Article  Google Scholar 

  4. Daneshmand S, Ahmadi H, Huynh LN, Dobos N. Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology. 2012;80(6):1313–8.

    Article  Google Scholar 

  5. Nguyen HT, Pohar KS, Jia G, Shah ZK, Mortazavi A, Zynger DL, Wei L, Clark D, Yang X, Knopp MV. Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging. Investig Radiol. 2014;49(6):390–5.

    Article  Google Scholar 

  6. Bashir U, Ahmed I, Bashir O, Azam M, Faruqui ZS, Uddin N. Diagnostic accuracy of high resolution MR imaging in local staging of bladder tumors. J Coll Physicians Surg Pak. 2014;24(5):314–7.

    PubMed  Google Scholar 

  7. Zhou G, Chen X, Zhang J, Zhu J, Zong G, Wang Z. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer. Eur J Radiol. 2014;83(11):2013–8.

    Article  Google Scholar 

  8. Liedberg F, Bendahl PO, Davidsson T, Gudjonsson S, Holmer M, Månsson W, Wallengren NO. Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol. Scand J Urol. 2013;47(2):108–12.

    Article  Google Scholar 

  9. Maurer T, Eiber M, Krause BJ. [Molecular multimodal hybrid imaging in prostate and bladder cancer]. Urologe A. 2014a;53(4):469–83.

    Google Scholar 

  10. Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scand J Urol Nephrol. 2011;45(2):122–8.

    Article  Google Scholar 

  11. Maurer T, Horn T, Souvatzoglou M, Eiber M, Beer AJ, Heck MM, Haller B, Gschwend JE, Schwaiger M, Treiber U, Krause BJ. Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy. Urol Int. 2014b;93(2):207–13.

    Article  CAS  Google Scholar 

  12. Mertens LS, Mir MC, Scott AM, Lee ST, Fioole-Bruining A, Vegt E, Vogel WV, Manecksha R, Bolton D, Davis ID, Horenblas S, van Rhijn BW, Lawrentschuk N. 18F-Fluorodeoxyglucose—positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer. Urology. 2014;83(2):393–8.

    Article  Google Scholar 

  13. Nayak B, Dogra PN, Naswa N, Kumar R. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique. Eur J Nucl Med Mol Imaging. 2013;40(3):386–93.

    Article  CAS  Google Scholar 

  14. Kollberg P, Almquist H, Bläckberg M, Cronberg C, Garpered S, Gudjonsson S, Kleist J, Lyttkens K, Patschan O, Liedberg F. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy. Scand J Urol. 2015;49(4):296–301.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Goonewardene, S.S., Ventii, K., Bahl, A., Persad, R., Motiwala, H., Albala, D. (2021). Muscle Invasive Bladder Cancer and the Staging Conundrum: Which Imaging Modality Is Best?. In: Management of Muscle Invasive Bladder Cancer. Management of Urology. Springer, Cham. https://doi.org/10.1007/978-3-030-57915-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-57915-9_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-57914-2

  • Online ISBN: 978-3-030-57915-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics